Clinical Trials Directory

Trials / Completed

CompletedNCT03403582

Raspberries and Postprandial Metabolism

Raspberries, Postprandial Metabolism and Type 2 Diabetes Mellitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Oklahoma State University · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Accepted

Summary

Raspberries are high in several phytochemicals, vitamin C and B vitamins and have been shown to be potent antioxidants and anti-inflammatory agents. However, human interventional studies reporting the effects of raspberries in obesity, T2DM and associated oxidative stress and inflammation are limited. Aims, objectives and methods: Aim 1: To assess the effects of raspberries in postprandial glycemia and lipemia following a high-fat fast-food style meal challenge versus control group Objectives: to execute this aim, the investigators will conduct analyses of serum glucose, insulin and lipids (total cholesterol, LDL-cholesterol, triglycerides, VLDL-cholesterol and HDL-cholesterol) at fasting (baseline) and at postprandial 1,2,4 hours of high-fat, fast food style breakfast consumption. The investigators will also calculate homoeostasis model assessment of insulin resistance (HOMA-IR) at these time points using serum glucose and insulin values. Aim 2: To assess the effects of raspberries in postprandial vascular functions (blood pressure and artery elasticity) and inflammation following a high-fat fast food style meal challenge versus control group Objectives: to execute this aim, the investigators will measure C-reactive protein (CRP) and the following parameters of vascular function associated with CVD at fasting (baseline) and at postprandial 1,2,4 hours of high-fat, fast food style breakfast consumption: * systolic blood pressure and diastolic blood pressure * large artery elasticity index and small artery elasticity index * systemic vascular resistance

Conditions

Interventions

TypeNameDescription
OTHERRaspberries250g frozen whole red raspberries

Timeline

Start date
2014-12-01
Primary completion
2016-09-01
Completion
2017-12-01
First posted
2018-01-18
Last updated
2018-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03403582. Inclusion in this directory is not an endorsement.